Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has been included on the recently published list of brands that have submitted Novel Foods applications to the UK Food Standard Agencies (FSA) for their cannabidiol (CBD) products.
According to the Association for the Cannabinoid Industry (ACI), the UK’s total sales of CBD products in 2021 was £690 million, making it the second-largest market for consumer CBD, only slightly behind the U.S.
This new list
contains the names of products that were on the market before February 13,
2020, and have demonstrated a comprehensive toxicological approach to confirm
safety. The FSA states that any companies on this list can continue to market
their products within the UK, and those that are not should discontinue all